Prezista Sales Data

Rank 60 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Prezista U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 60 (1) 3.54% 3.10%
Q3 2013 61 (1) -1.67% -3.37%
Q2 2013 60 (9) 9.23% 8.98%
Q1 2013 69 (3) 4.35% -0.41%
Q4 2012 72 (11) 10.09% 11.31%
Q3 2012 83 (3) 1.17% 0.91%
Q2 2012 80 (9) 6.35% 5.80%
Q1 2012 89 (9) 9.20% 4.02%
Q4 2011 98 (2) 7.73% 7.57%
Q3 2011 100 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
December 20, 2011HIV/AIDS Update - Updated Information About Prezista (Darunavir): Oral Suspension and Labeling Changes
December 14, 2010Once-Daily Dose Approved for Prezista
Hide
(web4)